Kosalaram Goteti

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Ankylosing Spondylitis

Systemic Lupus Erythematosus

Top Venues

Clinical pharmacology and therapeutics

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Lena Klopp-Schulze, Sathej Gopalakrishnan, Özkan Yalkinoglu, Yoshihiro Kuroki, Hong Lu, Kosalaram Goteti, Axel Krebs-Brown, Marco Nogueira Filho, Ulrike Gradhand, Markus Fluck, Jamie Shaw, Jennifer Dong, Karthik Venkatakrishnan
Asia-Inclusive Global Development of Enpatoran: Results of an Ethno-Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial. Clinical pharmacology and therapeutics (2024)
Aarti Sawant-Basak, Shweta Urva, Jatinder Kaur Mukker, Sebastian Haertter, Dean Mariano, Dolly A Parasrampuria, Kosalaram Goteti, Ravi Shankar Prasad Singh, Manoj S Chiney, Michael Z Liao, Sandy S Chang, Rashmi Mehta
Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper. Clinical pharmacology and therapeutics (2024)
Lena Klopp-Schulze, Sathej Gopalakrishnan, Özkan Yalkinoglu, Yoshihiro Kuroki, Hong Lu, Kosalaram Goteti, Axel Krebs-Brown, Marco Nogueira Filho, Ulrike Gradhand, Markus Fluck, Jamie Shaw, Jennifer Dong, Karthik Venkatakrishnan
Asia-Inclusive Global Development of Enpatoran: Results of an Ethno-Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial. Clinical pharmacology and therapeutics 115 (6) (2024)
Kosalaram Goteti, Nathan Hanan, Mindy Magee, Jessica Wojciechowski, Sven Mensing, Bojan Lalovic, Yaming Hang, Alexander Solms, Indrajeet Singh, Rajendra Singh, Theodore Robert Rieger, Jin Y Jin
Opportunities and Challenges of Disease Progression Modeling in Drug Development - An IQ Perspective. Clinical pharmacology and therapeutics (2023)
Kosalaram Goteti, Nathan Hanan, Mindy Magee, Jessica Wojciechowski, Sven Mensing, Bojan Lalovic, Yaming Hang, Alexander Solms, Indrajeet Singh, Rajendra Singh, Theodore Robert Rieger, Jin Y Jin
Opportunities and Challenges of Disease Progression Modeling in Drug Development - An IQ Perspective. Clinical pharmacology and therapeutics (2023)
Kosalaram Goteti, Ramon Garcia, William R Gillespie, Jonathan L French, Lena Klopp-Schulze, Ying Li, Cristina Vazquez Mateo, Sanjeev Roy, Oliver Guenther, Lisa Benincosa, Karthik Venkatakrishnan
Model-based meta-analysis using latent variable modeling to set benchmarks for new treatments of systemic lupus erythematosus. CPT: pharmacometrics & systems pharmacology (2023)
Yulia Vugmeyster, Abhigyan Ravula, Elisabeth Rouits, Paul Matthias Diderichsen, Huub Jan Kleijn, Andre Koenig, XiaoZhe Wang, Andreas Schroeder, Kosalaram Goteti, Karthik Venkatakrishnan
Model-informed selection of the recommended phase 3 dose of the inhibitor of apoptosis protein inhibitor, xevinapant, in combination with cisplatin and concurrent radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck. Clinical pharmacology and therapeutics (2023)
Kosalaram Goteti, Jonathan L French, Ramon Garcia, Ying Li, Florence Casset-Semanaz, Aida Aydemir, Robert Townsend, Cristina Vazquez Mateo, Matthew Studham, Oliver Guenther, Amy Kao, Marc R Gastonguay, Pascal Girard, Lisa Benincosa, Karthik Venkatakrishnan
Disease trajectory of SLE clinical endpoints and covariates affecting disease severity and probability of response: Analysis of pooled patient-level placebo (Standard-of-Care) data to enable model-informed drug development. CPT: pharmacometrics & systems pharmacology (2022)